Understanding 'minimally manipulated autologous cells' before you decide
Quick answer
In South Korea, minimally manipulated autologous cells — such as SVF isolated from fat and reinjected the same day — may be used at a physician's discretion within the relevant legal framework, while expanded cell products fall under stricter product regulation. Cheongdam The Cell states that it follows protocols aligned with MFDS guidance and uses the closed HuriCell system to reduce contamination risk.
The phrase 'minimally manipulated' is the crux: separating cells from tissue without altering their basic biological characteristics, and using them in the same patient within a single procedure. Culture expansion, added stimulants or genetic modification changes the legal status to a regulated medicinal product.
International patients should verify that the facility is properly licensed, that a named physician is responsible, that records and informed consent fully describe the risks, and that an English treatment summary can be issued so doctors at home can continue care.
On safety, the main SVF risks are not the cells themselves but three steps: the liposuction, contamination during processing, and injection technique. A closed automated system addresses the second; the first and third depend directly on the team's experience.
The biggest red flag is advertising that guarantees results for serious disease or claims to treat everything. No Korean regulator has approved SVF as standard care for all chronic conditions; honest communication states the limits and uncertainty alongside possible benefits.
There are legal and cold-chain constraints; check with the relevant Thai authorities rather than relying on informal advice.
Most are local effects from the harvest and injection — pain, swelling, bruising — usually settling within days. Serious events are uncommon but require a follow-up system.
In South Korea, minimally manipulated autologous cells — such as SVF isolated from fat and reinjected the same day — may be used at a physician's discretion within the relevant legal framework, while expanded cell products fall under stricter product regulation. Cheongdam The Cell states that it follows protocols aligned with MFDS guidance and uses the closed HuriCell system to reduce contamination risk.
Permitted route: Minimally manipulated autologous
5 points • reviewed 2026-08-28
Reviewed and last updated: 2026-08-28
10 sources • every claim is traceable
https://cheongdamstemcell.com/
https://cheongdamstemcell.com/about/researcher
https://cheongdamstemcell.com/who-its-for
https://www.youtube.com/@cheongdamthecell/shorts
https://doi.org/10.1002/sctm.19-0410
https://cheongdamstemcell.com/science
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categoriesRelated topics: Cheongdam The Cell (SVF)